Clinical Microbiology Market by Product (Instrument (Incubators), Analyzer (Microscope), Reagent, Kits, Media], Disease Area (Respiratory, Gastrointestinal, STD, UTI), End User (Hospitals, Diagnostic Center, Research Institutes) - Global Forecast to 2030

1 INTRODUCTION 35 1.1 STUDY OBJECTIVES 35 1.2 MARKET DEFINITION 35 1.3 MARKET SCOPE 36 1.3.1 MARKETS & REGIONS COVERED 36 1.3.2 INCLUSIONS & EXCLUSIONS 37 1.3.3 YEARS CONSIDERED 38 1.3.4 CURRENCY CONSIDERED 38 1.4 KEY STAKEHOLDERS 38 1.5 SUMMARY OF CHANGES 39 2 RESEARCH METHODOLOGY 40 2.1 RESEARCH DATA 40 2.2 RESEARCH APPROACH 40 2.2.1 SECONDARY DATA 41 2.2.1.1 Key secondary sources 41 2.2.1.2 Key data from secondary sources 42 2.2.2 PRIMARY DATA 43 2.2.2.1 Primary sources 43 2.2.2.2 Key data from primary sources 44 2.2.2.3 Key industry insights 45 2.2.2.4 Breakdown of primary interviews 45 2.3 MARKET SIZE ESTIMATION 46 2.3.1 BOTTOM-UP APPROACH 46 2.3.1.1 Approach 1: Company revenue estimation approach 47 2.3.1.2 Approach 2: Presentations of companies and primary interviews 47 2.3.1.3 Growth forecast 47 2.3.1.4 CAGR projections 48 2.3.2 TOP-DOWN APPROACH 48 2.4 MARKET BREAKDOWN & DATA TRIANGULATION 50 2.5 MARKET SHARE ASSESSMENT 51 2.6 RESEARCH ASSUMPTIONS 51 2.7 RESEARCH LIMITATIONS 51 2.8 RISK ASSESSMENT 52 3 EXECUTIVE SUMMARY 53   4 PREMIUM INSIGHTS 57 4.1 CLINICAL MICROBIOLOGY MARKET OVERVIEW 57 4.2 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 58 4.3 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2025 VS. 2030 (USD MILLION) 58 4.4 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 59 4.5 CLINICAL MICROBIOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59 5 MARKET OVERVIEW 60 5.1 INTRODUCTION 60 5.2 MARKET DYNAMICS 60 5.2.1 DRIVERS 61 5.2.1.1 Technological advancements and development of novel molecular diagnostic-based instruments 61 5.2.1.2 Rising incidence of infectious diseases and epidemics 62 5.2.1.3 Increasing focus on R&D programs and public-private investments 63 5.2.2 RESTRAINTS 64 5.2.2.1 Limited reimbursement policies for clinical microbiology testing procedures 64 5.2.3 OPPORTUNITIES 64 5.2.3.1 Improved healthcare infrastructure in emerging economies 64 5.2.4 CHALLENGES 65 5.2.4.1 Operational barriers for diagnostic microbiology tests 65 5.3 PRICING ANALYSIS 65 5.3.1 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS 65 5.3.2 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY TEST KITS, BY KEY PLAYER, 2023−2025 66 5.3.3 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS, BY REGION, 2023−2025 67 5.4 PATENT ANALYSIS 68 5.4.1 LIST OF MAJOR PATENTS 69 5.5 VALUE CHAIN ANALYSIS 70 5.6 SUPPLY CHAIN ANALYSIS 71 5.7 TRADE ANALYSIS 72 5.7.1 TRADE ANALYSIS FOR OPTICAL MICROSCOPES 72 5.7.2 IMPORT DATA (HS CODE 9011) 73 5.7.3 EXPORT DATA (HS CODE 9011) 73 5.8 ECOSYSTEM ANALYSIS 74 5.8.1 CLINICAL MICROBIOLOGY MARKET: ROLE IN ECOSYSTEM 74 5.9 PORTER’S FIVE FORCES ANALYSIS 75 5.9.1 THREAT OF NEW ENTRANTS 76 5.9.2 THREAT OF SUBSTITUTES 76 5.9.3 BARGAINING POWER OF BUYERS 76 5.9.4 BARGAINING POWER OF SUPPLIERS 77 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 77 5.10 REGULATORY LANDSCAPE 77 5.10.1 REGULATORY FRAMEWORK 77 5.10.1.1 North America 77 5.10.1.1.1 US 77 5.10.1.1.2 Canada 77 5.10.1.2 Europe 78 5.10.1.2.1 Germany 78 5.10.1.2.2 UK 79 5.10.1.2.3 France 79 5.10.1.2.4 Italy 79 5.10.1.3 Asia Pacific 80 5.10.1.3.1 China 80 5.10.1.3.2 Japan 80 5.10.1.3.3 India 80 5.10.1.4 Latin America 81 5.10.1.4.1 Brazil 81 5.10.1.4.2 Mexico 81 5.10.1.5 Middle East 81 5.10.1.5.1 Africa 82 5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 5.11 TECHNOLOGY ANALYSIS 84 5.11.1 KEY TECHNOLOGIES 84 5.11.1.1 MALDI-TOF mass spectrometry 84 5.11.2 COMPLEMENTARY TECHNOLOGIES 84 5.11.2.1 Optical immunosensors 85 5.11.2.2 Electrochemical immunosensors 85 5.11.3 ADJACENT TECHNOLOGIES 85 5.11.3.1 Automated multiplex PCR systems 85 5.12 KEY CONFERENCES & EVENTS, 2025–2026 85 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 87 5.14 KEY STAKEHOLDERS & BUYING CRITERIA 88 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 88 5.14.2 BUYING CRITERIA 89 5.15 INVESTMENT & FUNDING SCENARIO 89 5.16 CASE STUDY ANALYSIS 90 5.16.1 CASE STUDY 1: IMPACT OF MALDI-TOF MS AND RAPID SUSCEPTIBILITY TESTING ON SEPSIS MANAGEMENT 90 5.16.2 CASE STUDY 2: IMPACT OF MULTIPLEX PCR PANELS IN MANAGING ACUTE GASTROENTERITIS IN ED 91   5.17 IMPACT OF AI/GENERATIVE AI IN CLINICAL MICROBIOLOGY MARKET 91 5.17.1 INTRODUCTION 91 5.17.2 MARKET POTENTIAL OF AI 92 5.17.3 AI-USE CASES 92 5.17.4 IMPLEMENTATION OF AI, BY KEY COMPANY & CASE 93 5.17.5 FUTURE OF AI IN CLINICAL MICROBIOLOGY MARKET 94 5.18 TRUMP TARIFF IMPACT ON CLINICAL MICROBIOLOGY MARKET 94 5.18.1 INTRODUCTION 94 5.18.2 KEY TARIFF RATES 95 5.18.3 PRICE IMPACT ANALYSIS 95 5.18.4 KEY IMPACT ON COUNTRY/REGION 96 5.18.4.1 North America 96 5.18.4.2 Europe 96 5.18.4.3 Asia Pacific 96 5.18.5 IMPACT ON END-USE INDUSTRIES 96 5.18.5.1 Hospitals & diagnostic centers 96 5.18.5.2 Contract testing laboratories 97 5.18.5.3 Academic & research institutes 97 6 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT 98 6.1 INTRODUCTION 99 6.2 INSTRUMENTS 99 6.2.1 LABORATORY INSTRUMENTS 103 6.2.1.1 Incubators 106 6.2.1.1.1 Rising demand for cell culture applications to drive market 106 6.2.1.2 Gram stainers 109 6.2.1.2.1 Rapid, accurate screening of bacterial pathogens to fuel uptake 109 6.2.1.3 Bacterial colony counters 112 6.2.1.3.1 Increased focus on accurate bacterial quantification to drive market 112 6.2.1.4 Autoclave sterilizers 115 6.2.1.4.1 Increasing focus on infection control in healthcare facilities to support market growth 115 6.2.1.5 Microbial air samplers 118 6.2.1.5.1 Need for enhanced air quality monitoring in cleanrooms to accelerate segment growth 118 6.2.1.6 Anaerobic culture systems 121 6.2.1.6.1 Increased research on anaerobic microorganisms to boost segment growth 121 6.2.1.7 Petri dish fillers 124 6.2.1.7.1 Need for minimal bench space and effective control with graphical user interfaces to aid segment growth 124   6.2.1.8 Blood culture systems 127 6.2.1.8.1 Technological advancements in diagnostic testing to drive market 127 6.2.1.9 Microbial culture systems 130 6.2.1.9.1 Increase in biopharmaceutical research to augment segment growth 130 6.2.1.10 Other laboratory instruments 133 6.2.2 MICROBIOLOGY ANALYZERS 136 6.2.2.1 Molecular diagnostic instruments 140 6.2.2.1.1 Advancements in multiplexing techniques and high adoption of genomics-based analysis to aid market growth 140 6.2.2.2 Microscopes 143 6.2.2.2.1 Rising demand for high-resolution imaging to propel market 143 6.2.2.3 Mass spectrometers 146 6.2.2.3.1 Increased applications in proteomics & metabolomics to boost market 146 6.3 REAGENTS 148 6.3.1 PATHOGEN-SPECIFIC KITS 152 6.3.1.1 Increasing private-public initiatives for research to support market growth 152 6.3.2 GENERAL REAGENTS 154 6.3.2.1 Rising demand for diagnostic tests for pathogen detection to propel segment growth 154 6.4 MEDIA & SERA 157 6.4.1 RISING DEMAND FOR STANDARDIZED CULTURE MEDIA FOR MICROBIOLOGICAL TESTING TO PROPEL MARKET 157 7 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA 161 7.1 INTRODUCTION 162 7.2 RESPIRATORY DISEASES 162 7.2.1 EXPANSION OF RESPIRATORY DISEASE SURVEILLANCE PROGRAMS TO DRIVE MARKET 162 7.3 BLOODSTREAM INFECTIONS 166 7.3.1 GROWING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS TO DRIVE MARKET 166 7.4 GASTROINTESTINAL DISEASES 169 7.4.1 HIGH RISK OF FOOD- AND WATER-BORNE INFECTIONS TO AID MARKET 169 7.5 SEXUALLY TRANSMITTED DISEASES 172 7.5.1 INCREASING EMPHASIS ON EARLY & EFFECTIVE DISEASE DIAGNOSIS TO BOOST DEMAND 172 7.6 URINARY TRACT INFECTIONS 176 7.6.1 FOCUS ON PREVENTIVE CARE TO SUPPORT MARKET GROWTH 176 7.7 PERIODONTAL DISEASES 179 7.7.1 INCREASING R&D INITIATIVES TO STUDY MICROBE-INDUCED DISEASES TO FUEL MARKET 179 7.8 OTHER DISEASES 182 8 CLINICAL MICROBIOLOGY MARKET, BY END USER 186 8.1 INTRODUCTION 187 8.2 HOSPITALS & DIAGNOSTIC CENTERS 187 8.2.1 INCREASING PATIENT VOLUME AND RISING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET 187 8.3 CONTRACT TESTING LABORATORIES 191 8.3.1 LOW-COST OUTSOURCING OF TESTING ACTIVITIES TO LABORATORIES TO PROPEL MARKET 191 8.4 ACADEMIC & RESEARCH INSTITUTES 194 8.4.1 EXPANSION OF RESEARCH INITIATIVES AND FAVORABLE FUNDING INVESTMENTS TO BOOST MARKET 194 9 CLINICAL MICROBIOLOGY MARKET, BY REGION 197 9.1 INTRODUCTION 198 9.2 NORTH AMERICA 199 9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 204 9.2.2 US 205 9.2.2.1 Increasing prevalence of infectious diseases to drive market 205 9.2.3 CANADA 209 9.2.3.1 Supportive government initiatives and increased research funding to boost market 209 9.3 EUROPE 213 9.3.1 EUROPE: MACROECONOMIC OUTLOOK 217 9.3.2 GERMANY 218 9.3.2.1 Favorable government policies to propel market 218 9.3.3 FRANCE 222 9.3.3.1 Favorable healthcare reforms and investments in diagnostic infrastructure to drive market 222 9.3.4 UK 226 9.3.4.1 Rising acceptance of genome-based diagnostic techniques to fuel market 226 9.3.5 ITALY 230 9.3.5.1 Improved healthcare services and better disease surveillance to support market growth 230 9.3.6 SPAIN 234 9.3.6.1 Growing focus on public healthcare initiatives to augment market growth 234 9.3.7 REST OF EUROPE 238 9.4 ASIA PACIFIC 242 9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 246 9.4.2 CHINA 247 9.4.2.1 Increasing government focus on disease prevention to drive market 247   9.4.3 JAPAN 251 9.4.3.1 Technological advancements in diagnostic kits to fuel uptake 251 9.4.4 INDIA 255 9.4.4.1 High target patient population to boost demand 255 9.4.5 SOUTH KOREA 259 9.4.5.1 Favorable government initiatives for medical tourism to support market growth 259 9.4.6 AUSTRALIA 263 9.4.6.1 Favorable healthcare automation techniques to support market growth 263 9.4.7 REST OF ASIA PACIFIC 267 9.5 LATIN AMERICA 271 9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 275 9.5.2 BRAZIL 276 9.5.2.1 Universal healthcare access to drive market 276 9.5.3 MEXICO 279 9.5.3.1 Increasing prevalence of HIV to drive market 279 9.5.4 REST OF LATIN AMERICA 283 9.6 MIDDLE EAST & AFRICA 287 9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 292 9.6.2 KINGDOM OF SAUDI ARABIA (KSA) 292 9.6.2.1 Increasing focus on healthcare automation to drive market 292 9.6.3 UNITED ARAB EMIRATES (UAE) 296 9.6.3.1 Improvements in healthcare infrastructure to support market growth 296 9.6.4 REST OF MIDDLE EAST & AFRICA 300 10 COMPETITIVE LANDSCAPE 304 10.1 INTRODUCTION 304 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 304 10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET 304 10.3 REVENUE SHARE ANALYSIS 307 10.4 MARKET SHARE ANALYSIS, 2024 308 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 310 10.5.1 STARS 310 10.5.2 EMERGING LEADERS 310 10.5.3 PERVASIVE PLAYERS 310 10.5.4 PARTICIPANTS 310 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 312 10.5.5.1 Company footprint 312 10.5.5.2 Region footprint 312 10.5.5.3 Product footprint 313 10.5.5.4 Instruments footprint 314 10.5.5.5 Disease area footprint 314 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 315 10.6.1 PROGRESSIVE COMPANIES 315 10.6.2 RESPONSIVE COMPANIES 315 10.6.3 DYNAMIC COMPANIES 315 10.6.4 STARTING BLOCKS 315 10.6.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 317 10.6.5.1 Detailed list of key startups/SMEs 317 10.6.5.2 Competitive benchmarking of startups/SMEs (1/2) 317 10.6.5.3 Competitive benchmarking of startups/SMEs (2/2) 318 10.7 COMPANY VALUATION & FINANCIAL METRICS 318 10.7.1 FINANCIAL METRICS 318 10.7.2 COMPANY VALUATION 319 10.8 BRAND/PRODUCT COMPARISON 319 10.8.1 BRAND/PRODUCT COMPARATIVE ANALYSIS 319 10.9 COMPETITIVE SCENARIO 320 10.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 320 10.9.2 DEALS 321 10.9.3 EXPANSIONS 322 11 COMPANY PROFILES 323 11.1 KEY PLAYERS 323 11.1.1 BIOMÉRIEUX 323 11.1.1.1 Business overview 323 11.1.1.2 Products/Services offered 325 11.1.1.3 Recent developments 327 11.1.1.3.1 Product/Service launches & approvals 327 11.1.1.3.2 Deals 328 11.1.1.4 MnM view 330 11.1.1.4.1 Key strengths 330 11.1.1.4.2 Strategic choices 330 11.1.1.4.3 Weaknesses & competitive threats 330 11.1.2 DANAHER CORPORATION 331 11.1.2.1 Business overview 331 11.1.2.2 Products/Services offered 333 11.1.2.3 Recent developments 334 11.1.2.3.1 Product/Service launches & approvals 334 11.1.2.3.2 Deals 335 11.1.2.3.3 Expansions 335 11.1.2.4 MnM view 336 11.1.2.4.1 Key strengths 336 11.1.2.4.2 Strategic choices 336 11.1.2.4.3 Weaknesses & competitive threats 336 11.1.3 BECTON, DICKINSON AND COMPANY (BD) 337 11.1.3.1 Business overview 337 11.1.3.2 Products/Services offered 338 11.1.3.3 Recent developments 340 11.1.3.3.1 Product/Service launches & approvals 340 11.1.3.3.2 Deals 341 11.1.3.3.3 Expansions 342 11.1.3.4 MnM view 342 11.1.3.4.1 Key strengths 342 11.1.3.4.2 Strategic choices 342 11.1.3.4.3 Weaknesses & competitive threats 342 11.1.4 THERMO FISHER SCIENTIFIC INC. 343 11.1.4.1 Business overview 343 11.1.4.2 Products/Services offered 344 11.1.4.3 Recent developments 347 11.1.4.3.1 Product/Service launches & approvals 347 11.1.4.3.2 Deals 348 11.1.4.4 MnM view 348 11.1.4.4.1 Key strengths 348 11.1.4.4.2 Strategic choices 348 11.1.4.4.3 Weaknesses & competitive threats 348 11.1.5 F. HOFFMANN-LA ROCHE LTD. 349 11.1.5.1 Business overview 349 11.1.5.2 Products/Services offered 350 11.1.5.3 Recent developments 351 11.1.5.3.1 Product/Service launches & approvals 351 11.1.5.3.2 Deals 352 11.1.5.3.3 Expansions 352 11.1.5.4 MnM view 353 11.1.5.4.1 Key strengths 353 11.1.5.4.2 Strategic choices 353 11.1.5.4.3 Weaknesses & competitive threats 353 11.1.6 ABBOTT LABORATORIES 354 11.1.6.1 Business overview 354 11.1.6.2 Products/Services offered 356 11.1.6.3 Recent developments 361 11.1.6.3.1 Deals 361 11.1.7 AGILENT TECHNOLOGIES, INC. 362 11.1.7.1 Business overview 362 11.1.7.2 Products/Services offered 363 11.1.7.3 Recent developments 364 11.1.7.3.1 Expansions 364 11.1.8 BRUKER CORPORATION 365 11.1.8.1 Business overview 365 11.1.8.2 Products/Services offered 366 11.1.8.3 Recent developments 367 11.1.8.3.1 Product/Service launches & approvals 367 11.1.8.3.2 Deals 367 11.1.9 HOLOGIC, INC. 368 11.1.9.1 Business overview 368 11.1.9.2 Products/Services offered 369 11.1.9.3 Recent developments 370 11.1.9.3.1 Product/Service launches & approvals 370 11.1.9.3.2 Deals 371 11.1.10 MERCK KGAA 372 11.1.10.1 Business overview 372 11.1.10.2 Products/Services offered 373 11.1.10.3 Recent developments 374 11.1.10.3.1 Deals 374 11.1.10.3.2 Expansions 374 11.1.11 BIO-RAD LABORATORIES, INC. 376 11.1.11.1 Business overview 376 11.1.11.2 Products/Services offered 377 11.1.11.3 Recent developments 379 11.1.11.3.1 Deals 379 11.1.12 QIAGEN 380 11.1.12.1 Business overview 380 11.1.12.2 Products/Services offered 381 11.1.12.3 Recent developments 382 11.1.12.3.1 Product/Service launches 382 11.1.12.3.2 Deals 383 11.1.12.3.3 Expansions 383 11.1.13 SIEMENS HEALTHINEERS AG 384 11.1.13.1 Business overview 384 11.1.13.2 Products/Services offered 385 11.1.13.3 Recent developments 386 11.1.13.3.1 Product/Service launches 386 11.1.13.3.2 Deals 386 11.1.13.3.3 Expansions 387   11.2 OTHER PLAYERS 388 11.2.1 SHIMADZU CORPORATION 388 11.2.2 NEOGEN CORPORATION 389 11.2.3 SEEGENE INC. 390 11.2.4 RAPID MICRO BIOSYSTEMS, INC. 391 11.2.5 HARDY DIAGNOSTICS 392 11.2.6 EMSL ANALYTICAL, INC. 395 11.2.7 LIOFILCHEM S.R.L. 396 11.2.8 TCS BIOSCIENCES LTD. 397 11.2.9 MEMMERT GMBH + CO.KG 398 11.2.10 VACUTEST KIMA S.R.L 399 11.2.11 CREATIVE DIAGNOSTICS 400 11.2.12 DCN DX 401 12 APPENDIX 402 12.1 DISCUSSION GUIDE 402 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 407 12.3 CUSTOMIZATION OPTIONS 409 12.4 RELATED REPORTS 409 12.5 AUTHOR DETAILS 410

TABLE 1 CLINICAL MICROBIOLOGY MARKET: INCLUSIONS & EXCLUSIONS 37 TABLE 2 CLINICAL MICROBIOLOGY MARKET: KEY DATA FROM PRIMARY SOURCES 44 TABLE 3 CLINICAL MICROBIOLOGY MARKET: RISK ASSESSMENT ANALYSIS 52 TABLE 4 AVERAGE SELLING PRICING TREND OF CLINICAL MICROBIOLOGY PRODUCTS, 2023–2025 66 TABLE 5 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY TEST KITS & ASSAYS, BY KEY PLAYER, 2023–2025 66 TABLE 6 AVERAGE SELLING PRICE TREND OF CLINICAL MICROBIOLOGY PRODUCTS, BY REGION, 2023–2025 67 TABLE 7 LIST OF MAJOR PATENTS, 2023–2025 69 TABLE 8 IMPORT DATA FOR OPTICAL MICROSCOPES (HS CODE 9011), BY COUNTRY, 2020–2024 (USD MILLION) 73 TABLE 9 EXPORT DATA FOR OPTICAL MICROSCOPES (HS CODE 3822), BY COUNTRY, 2020–2024 (USD MILLION) 73 TABLE 10 CLINICAL MICROBIOLOGY MARKET: ROLE IN ECOSYSTEM 74 TABLE 12 CLASSIFICATION OF IVD DEVICES IN EUROPE 78 TABLE 13 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 80 TABLE 16 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 19 CLINICAL MICROBIOLOGY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 86 TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CLINICAL MICROBIOLOGY PRODUCTS (%) 88 TABLE 21 KEY BUYING CRITERIA FOR CLINICAL MICROBIOLOGY PRODUCTS 89 TABLE 22 KEY COMPANIES IMPLEMENTING AI 93 TABLE 23 US ADJUSTED RECIPROCAL TARIFF RATES 95 TABLE 24 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 99 TABLE 25 CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION) 100 TABLE 26 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 27 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 28 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 29 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 30 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 31 CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 102 TABLE 32 CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 33 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 34 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 35 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 36 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 37 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 38 CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 106 TABLE 39 CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 40 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 41 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 42 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 43 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 44 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INCUBATORS, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 45 CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY REGION, 2023–2030 (USD MILLION) 110 TABLE 46 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 47 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 48 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 49 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 50 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GRAM STAINERS, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 51 CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 52 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 53 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 54 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 55 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 56 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BACTERIAL COLONY COUNTERS, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 57 CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 58 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 59 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 60 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 61 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 62 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR AUTOCLAVE STERILIZERS, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 63 CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 64 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 65 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 66 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 67 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 68 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL AIR SAMPLERS, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 69 CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 70 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 71 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 72 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 73 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 74 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR ANAEROBIC CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 124 TABLE 75 CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 76 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 77 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 78 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 79 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 80 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PETRI DISH FILLERS, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 81 CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 82 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 83 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 84 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 85 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 86 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BLOOD CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 87 CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 88 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 89 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 90 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 91 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 92 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIAL CULTURE SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 93 CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 94 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 95 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 96 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 97 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 98 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET OTHER LABORATORY INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 99 LIST OF COMMERCIALLY AVAILABLE MICROBIOLOGY ANALYZERS, 2023–2025 137 TABLE 100 CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 101 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 102 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 103 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 104 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 105 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 106 CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 140 TABLE 107 CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY REGION, 2023–2030 (USD MILLION) 140 TABLE 108 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 109 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 110 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 111 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 112 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MOLECULAR DIAGNOSTICS INSTRUMENTS, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 113 CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 114 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 115 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 116 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 117 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 118 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROSCOPES, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 119 CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 120 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 121 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 122 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 123 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 124 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MASS SPECTROMETERS, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 125 CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 126 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 127 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 128 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 129 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 130 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 131 CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 132 CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 133 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 134 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 135 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 136 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 137 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PATHOGEN-SPECIFIC KITS, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 138 CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 139 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 140 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 141 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 142 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 143 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GENERAL REAGENTS, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 144 CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 145 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 146 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 147 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 148 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 149 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MEDIA & SERA, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 150 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 162 TABLE 151 GLOBAL NUMBER OF NEWLY DIAGNOSED TUBERCULOSIS (TB) CASES, 2023–2030 (IN MILLION) 164 TABLE 152 CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 153 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 154 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 155 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 156 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 157 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 158 CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY REGION, 2023–2030 (USD MILLION) 167 TABLE 159 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 160 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 161 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 162 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 163 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR BLOODSTREAM INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 164 CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2023–2030 (USD MILLION) 170 TABLE 165 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 166 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 167 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 168 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 169 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 170 CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2023–2030 (USD MILLION) 174 TABLE 171 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 172 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 173 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 174 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 175 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 176 CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2023–2030 (USD MILLION) 177 TABLE 177 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 178 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 179 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 180 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 181 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR URINARY TRACT INFECTIONS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 182 CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY REGION, 2023–2030 (USD MILLION) 180 TABLE 183 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 184 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 185 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 186 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 187 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 188 CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2023–2030 (USD MILLION) 183 TABLE 189 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 190 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 191 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 192 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 193 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 194 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 195 CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2023–2030 (USD MILLION) 188 TABLE 196 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 197 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 198 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 199 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 200 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 201 CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY REGION, 2023–2030 (USD MILLION) 191 TABLE 202 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 203 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 204 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 205 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 206 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR CONTRACT TESTING LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 207 CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 194 TABLE 208 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 209 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 210 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 211 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 212 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 213 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION) 198 TABLE 214 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 215 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 201 TABLE 216 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 217 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 218 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 219 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 220 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 203 TABLE 221 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 204 TABLE 222 NORTH AMERICA: MACROECONOMIC INDICATORS 204 TABLE 223 US: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 206 TABLE 224 US: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 225 US: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 226 US: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 227 US: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 228 US: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 208 TABLE 229 US: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 209 TABLE 230 CANADA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 210 TABLE 231 CANADA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 232 CANADA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 233 CANADA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 234 CANADA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 235 CANADA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 212 TABLE 236 CANADA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 213 TABLE 237 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 238 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 214 TABLE 239 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 240 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 241 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 242 EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 243 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 216 TABLE 244 EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 217 TABLE 245 EUROPE: MACROECONOMIC INDICATORS 217 TABLE 246 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 218 TABLE 247 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 248 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 249 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 250 GERMANY: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 251 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 221 TABLE 252 GERMANY: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 221 TABLE 253 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 222 TABLE 254 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 255 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 256 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 257 FRANCE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 258 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 225 TABLE 259 FRANCE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 225 TABLE 260 UK: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 227 TABLE 261 UK: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 262 UK: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 263 UK: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 264 UK: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 265 UK: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 229 TABLE 266 UK: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 230 TABLE 267 ITALY: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 231 TABLE 268 ITALY: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 269 ITALY: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 270 ITALY: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 271 ITALY: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 272 ITALY: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 233 TABLE 273 ITALY: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 234 TABLE 274 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 235 TABLE 275 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 276 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 277 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 278 SPAIN: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 279 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 237 TABLE 280 SPAIN: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 238 TABLE 281 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 238 TABLE 282 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 283 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 284 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 285 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 286 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 241 TABLE 287 REST OF EUROPE: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 241 TABLE 288 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 243 TABLE 289 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 243 TABLE 290 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 291 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 292 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 293 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 294 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 245 TABLE 295 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 246 TABLE 296 ASIA PACIFIC: MACROECONOMIC INDICATORS 246 TABLE 297 CHINA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 247 TABLE 298 CHINA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 299 CHINA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 300 CHINA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 301 CHINA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 302 CHINA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 250 TABLE 303 CHINA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 250 TABLE 304 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 252 TABLE 305 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 306 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 307 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 308 JAPAN: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 309 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 254 TABLE 310 JAPAN: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 255 TABLE 311 INDIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 256 TABLE 312 INDIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 313 INDIA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 314 INDIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 315 INDIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 316 INDIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 258 TABLE 317 INDIA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 259 TABLE 318 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 260 TABLE 319 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 320 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 321 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 322 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 323 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 262 TABLE 324 SOUTH KOREA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 263 TABLE 325 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 264 TABLE 326 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 327 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 328 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 329 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 330 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 266 TABLE 331 AUSTRALIA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 267 TABLE 332 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 268 TABLE 333 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 334 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 335 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 336 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 337 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 270 TABLE 338 REST OF ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 271 TABLE 339 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 272 TABLE 340 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 272 TABLE 341 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 342 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 343 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 344 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 345 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 274 TABLE 346 LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 275 TABLE 347 LATIN AMERICA: MACROECONOMIC INDICATORS 275 TABLE 348 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 276 TABLE 349 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 350 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 351 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 352 BRAZIL: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 353 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 279 TABLE 354 BRAZIL: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 279 TABLE 355 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 280 TABLE 356 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 357 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 358 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 359 MEXICO: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 360 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 282 TABLE 361 MEXICO: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 283 TABLE 362 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 284 TABLE 363 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 284 TABLE 364 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 365 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 366 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 367 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 286 TABLE 368 REST OF LATIN AMERICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 287 TABLE 369 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 288 TABLE 370 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 288 TABLE 371 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 372 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 373 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 374 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 375 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 291 TABLE 376 MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 291 TABLE 377 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 292 TABLE 378 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 293 TABLE 379 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 380 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 381 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 382 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 383 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 295 TABLE 384 KINGDOM OF SAUDI ARABIA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 296 TABLE 385 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 297 TABLE 386 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 387 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 388 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 389 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 390 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 299 TABLE 391 UNITED ARAB EMIRATES: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 300 TABLE 392 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 300 TABLE 393 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 394 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR LABORATORY INSTRUMENTS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 395 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR MICROBIOLOGY ANALYZERS, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 396 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET FOR REAGENTS, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 397 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2023–2030 (USD MILLION) 303 TABLE 398 REST OF MIDDLE EAST & AFRICA: CLINICAL MICROBIOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 303 TABLE 399 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET, JANUARY 2021−AUGUST 2025 304 TABLE 400 CLINICAL MICROBIOLOGY MARKET: INTENSITY OF COMPETITIVE RIVALRY 308 TABLE 401 CLINICAL MICROBIOLOGY MARKET: REGION FOOTPRINT 312 TABLE 402 CLINICAL MICROBIOLOGY MARKET: PRODUCT FOOTPRINT 313 TABLE 403 CLINICAL MICROBIOLOGY MARKET: INSTRUMENTS FOOTPRINT 314 TABLE 404 CLINICAL MICROBIOLOGY MARKET: DISEASE AREA FOOTPRINT 314 TABLE 405 CLINICAL MICROBIOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 317 TABLE 406 CLINICAL MICROBIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (1/2) 317 TABLE 407 CLINICAL MICROBIOLOGY MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES (2/2) 318 TABLE 408 CLINICAL MICROBIOLOGY MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025 320 TABLE 409 CLINICAL MICROBIOLOGY MARKET: DEALS, JANUARY 2021–AUGUST 2025 321 TABLE 410 CLINICAL MICROBIOLOGY MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2025 322 TABLE 411 BIOMÉRIEUX: COMPANY OVERVIEW 323 TABLE 412 BIOMÉRIEUX: PRODUCTS/SERVICES OFFERED 325 TABLE 413 BIOMÉRIEUX: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025 327 TABLE 414 BIOMÉRIEUX: DEALS, JANUARY 2021–AUGUST 2025 328 TABLE 415 DANAHER CORPORATION: COMPANY OVERVIEW 331 TABLE 416 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 333 TABLE 417 DANAHER CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025 334 TABLE 418 DANAHER CORPORATION: DEALS, JANUARY 2021–AUGUST 2025 335 TABLE 419 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021−AUGUST 2025 335 TABLE 420 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 337 TABLE 421 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES OFFERED 338 TABLE 422 BECTON, DICKINSON AND COMPANY: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025 340 TABLE 423 BECKTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–AUGUST 2025 341 TABLE 424 BECKTON, DICKINSON AND COMPANY: EXPANSIONS, JANUARY 2021– AUGUST 2025 342 TABLE 425 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 343 TABLE 426 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 344 TABLE 427 THERMO FISHER SCIENTIFIC INC.: PRODUCT/SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025 347 TABLE 428 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–AUGUST 2025 348 TABLE 429 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 349 TABLE 430 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED 350 TABLE 431 F. HOFFMANN-LA ROCHE LTD.: PRODUCT/SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2025 351 TABLE 432 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–AUGUST 2025 352 TABLE 433 F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2021–AUGUST 2025 352 TABLE 434 ABBOTT LABORATORIES: COMPANY OVERVIEW 354 TABLE 435 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED 356 TABLE 436 ABBOTT LABORATORIES: DEALS, JANUARY 2021−AUGUST 2025 361 TABLE 438 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 363 TABLE 439 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–AUGUST 2025 364 TABLE 440 BRUKER CORPORATION: COMPANY OVERVIEW 365 TABLE 441 BRUKER CORPORATION: PRODUCTS/SERVICES OFFERED 366 TABLE 442 BRUKER CORPORATION: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021– AUGUST 2025 367 TABLE 443 BRUKER CORPORATION: DEALS, JANUARY 2021– AUGUST 2025 367 TABLE 444 HOLOGIC, INC.: COMPANY OVERVIEW 368 TABLE 445 HOLOGIC, INC.: PRODUCTS/SERVICES OFFERED 369 TABLE 446 HOLOGIC, INC.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–AUGUST 2025 370 TABLE 447 HOLOGIC, INC.: DEALS, JANUARY 2021– AUGUST 2025 371 TABLE 448 MERCK KGAA: COMPANY OVERVIEW 372 TABLE 449 MERCK KGAA: PRODUCTS/SERVICES OFFERED 373 TABLE 450 MERCK KGAA: DEALS, JANUARY 2021–AUGUST 2025 374 TABLE 451 MERCK KGAA: EXPANSIONS, JANUARY 2021–AUGUST 2025 374 TABLE 452 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 376 TABLE 453 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 377 TABLE 454 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–AUGUST 2025 379 TABLE 455 QIAGEN: COMPANY OVERVIEW 380 TABLE 456 QIAGEN: PRODUCTS/SERVICES OFFERED 381 TABLE 457 QIAGEN: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–AUGUST 2025 382 TABLE 458 QIAGEN: DEALS, JANUARY 2021–AUGUST 2025 383 TABLE 459 QIAGEN: EXPANSIONS, JANUARY 2021–AUGUST 2025 383 TABLE 460 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 384 TABLE 461 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED 385 TABLE 462 SIEMENS HEALTHINEERS AG: PRODUCT/SERVICE LAUNCHES, JANUARY 2021–AUGUST 2025 386 TABLE 463 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021– AUGUST 2025 386 TABLE 464 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2021– AUGUST 2025 387 TABLE 465 SHIMADZU CORPORATION: COMPANY OVERVIEW 388 TABLE 466 NEOGEN CORPORATION: COMPANY OVERVIEW 389 TABLE 467 SEEGENE INC.: COMPANY OVERVIEW 390 TABLE 468 RAPID MICRO BIOSYSTEMS, INC.: COMPANY OVERVIEW 391 TABLE 469 HARDY DIAGNOSTICS: COMPANY OVERVIEW 392 TABLE 470 EMSL ANALYTICAL, INC.: COMPANY OVERVIEW 395 TABLE 471 LIOFILCHEM S.R.L.: COMPANY OVERVIEW 396 TABLE 472 TCS BIOSCIENCES LTD.: COMPANY OVERVIEW 397 TABLE 473 MEMMERT GMBH + CO.KG: COMPANY OVERVIEW 398 TABLE 474 VACUTEST KIMA S.R.L: COMPANY OVERVIEW 399 TABLE 475 CREATIVE DIAGNOSTICS: COMPANY OVERVIEW 400 TABLE 476 DCN DX: COMPANY OVERVIEW 401 FIGURE 1 CLINICAL MICROBIOLOGY MARKET SEGMENTATION & REGIONAL SCOPE 36 FIGURE 2 CLINICAL MICROBIOLOGY MARKET: RESEARCH DESIGN METHODOLOGY 40 FIGURE 3 PRIMARY SOURCES 43 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY & DEMAND-SIDE PARTICIPANTS 45 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 46 FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 47 FIGURE 7 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 48 FIGURE 8 CLINICAL MICROBIOLOGY MARKET: TOP-DOWN APPROACH 49 FIGURE 9 DATA TRIANGULATION METHODOLOGY 50 FIGURE 10 CLINICAL MICROBIOLOGY MARKET: RESEARCH ASSUMPTIONS 51 FIGURE 11 CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 53 FIGURE 12 CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA, 2025 VS. 2030 (USD MILLION) 54 FIGURE 13 CLINICAL MICROBIOLOGY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 55 FIGURE 14 CLINICAL MICROBIOLOGY MARKET, BY REGION, 2025 VS. 2030 (USD MILLION) 55 FIGURE 15 HIGH PREVALENCE OF INFECTIOUS DISEASES AND TECHNOLOGICAL ADVANCEMENTS IN NOVEL DIAGNOSTICS TO DRIVE MARKET 57 FIGURE 16 INSTRUMENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 58 FIGURE 17 RESPIRATORY DISEASES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 58 FIGURE 18 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 59 FIGURE 19 ASIA PACIFIC REGION TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 59 FIGURE 20 CLINICAL MICROBIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60 FIGURE 21 PATENT ANALYSIS FOR CLINICAL MICROBIOLOGY (JANUARY 2015–DECEMBER 2024) 68 FIGURE 22 VALUE CHAIN ANALYSIS OF CLINICAL MICROBIOLOGY MARKET: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES 70 FIGURE 23 CLINICAL MICROBIOLOGY MARKET: SUPPLY CHAIN ANALYSIS 72 FIGURE 24 CLINICAL MICROBIOLOGY MARKET: ECOSYSTEM ANALYSIS 74 FIGURE 25 CLINICAL MICROBIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 76 FIGURE 26 CLINICAL MICROBIOLOGY MARKET: TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 87 FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CLINICAL MICROBIOLOGY PRODUCTS 88 FIGURE 28 KEY BUYING CRITERIA FOR CLINICAL MICROBIOLOGY PRODUCTS 89 FIGURE 29 NUMBER OF DEALS & FUNDING ACTIVITIES IN CLINICAL MICROBIOLOGY MARKET (2021−2024) 90 FIGURE 30 MARKET POTENTIAL OF AI IN CLINICAL MICROBIOLOGY MARKET 92 FIGURE 31 NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 200 FIGURE 32 ASIA PACIFIC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT 242 FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET (2022–2024) 307 FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CLINICAL MICROBIOLOGY MARKET (2024) 308 FIGURE 35 CLINICAL MICROBIOLOGY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 311 FIGURE 36 CLINICAL MICROBIOLOGY MARKET: COMPANY FOOTPRINT 312 FIGURE 37 CLINICAL MICROBIOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 316 FIGURE 38 EV/EBITDA OF KEY VENDORS 318 FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 319 FIGURE 40 CLINICAL MICROBIOLOGY MARKET: BRAND COMPARISON FOR INSTRUMENTS 319 FIGURE 41 BIOMÉRIEUX: COMPANY SNAPSHOT (2024) 324 FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 332 FIGURE 43 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2024) 338 FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 344 FIGURE 45 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024) 350 FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2024) 355 FIGURE 47 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 363 FIGURE 48 BRUKER CORPORATION: COMPANY SNAPSHOT (2024) 366 FIGURE 49 HOLOGIC, INC.: COMPANY SNAPSHOT (2024) 369 FIGURE 50 MERCK KGAA: COMPANY SNAPSHOT (2024) 373 FIGURE 51 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 377 FIGURE 52 QIAGEN: COMPANY SNAPSHOT (2024) 381 FIGURE 53 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 385